Biomedical Research Education & Training
Faculty Member

Putnam, Joe B., M.D.
Chair of the Department of Thoracic Surgery
Professor of Thoracic Surgery
Ingram Professor of Cancer Research
Professor of Biomedical Informatics

Lab Url: http://Department of Thoracic Surgery

Phone Number: 615 343 9202

Email Address: bill.putnam@vanderbilt.edu

Putnam, Joe's picture
Academic history
A.B. with Honors, Univ of North Carolina, Chapel Hill
M.D., Univ of North Carolina, Chapel Hill
Intern, Johns Hopkins Hospital, Baltimore, MD
Resident, Johns Hopkins Hospital, Baltimore, MD
N/AN/A

Office Address   Mailing Address

1301 Medical Center Drive, 2971 The Vanderbilt Clinic

Department of Thoracic Surgery 2971 The Vanderbilt Clinic 37232-5734


Publications
Albert, JM, Gonzalez, A, Massion, PP, Chen, H, Olson, SJ, Shyr, Y, Diaz, R, Lambright, ES, Sandler, A, Carbone, DP, Putnam, JB, Johnson, DH, Lu, B. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer. Cancer Epidemiol Biomarkers Prev, 16(9), 1845-51, 2007

Antevil, JL, Putnam, JB. Talc pleurodesis for malignant effusions is preferred over the pleurx catheter (pro position). Ann Surg Oncol, 14(10), 2698-9, 2007

Putnam, JB. Invited commentary. Ann Thorac Surg, 83(2), 424, 2007

Karamichalis, JM, Putnam, JB, Lambright, ES. Cardiovascular complications after lung surgery. Thorac Surg Clin, 16(3), 253-60, 2006

Putnam, JB. Invited commentary. Ann Thorac Surg, 81(1), 285, 2006

Gaspar, LE, Gay EG, Crawford J, Putnam, JB Jr., Herbst RS, Bonner JA. Limited-Stage Small-Cell Lung Cancer (Stages I-III): Observations from the National Cancer Data Base. . Clin Lung Cancer, 6(6)(May), 355-60, 2005

Kim ES, Putnam, JB Jr., Jr., Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer, 44(3)(June), 369-79, 2005

Putnam, JB. Is resection necessary for esophageal carcinoma. Semin Oncol, 32(6 Suppl 9), S21-4, 2005

Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe RW, Swisher SG, Walsh GL, Putnam, JB Jr., Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thor Surg, 79(2)(Feb), 391-7, 2005

Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam, JB Jr., Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F] fluorodeoxyflucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol, Feb 20(236:), 1136-43, 2005

Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam, JB Jr., Dickey BF. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. . Ann Thor Surg, 79(5): (2005 May), 1704-10, 2005

Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam, JB Jr., Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection . AM J Gastroenterol, 99(7):(Jul;), 1258-66, 2004

Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam, JB Jr., Lynch PM, Wu TT, Smythe WR, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA . Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer, 100 (11)(Jun 1), 2347-54, 2004

Gassert HA, Casale AS, Creswell LL, Ferguson TB Jr., Fullerton DA, Kernstine KH, McMullan DM, Ring WS, Putnam, JB Jr. (Society of Thoracic Surgeons Workforce on Clinical Trials). Mentoring clinical trials in thoracic and cardiovascular surgery: a new role for the Society of Thoracic Surgeons . Ann Thorac Surg, 77(5)(May), 1874-5, 2004

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam, JB Jr., Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with respectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phy, 60(2)(Oct 1), 427-36, 2004

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Steven SW, Ho L, Smythe R, Vaporciyan AA, Putnam, JB Jr., Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys, 60(5)(Dec 1), 1484-93, 2004

Onn A, Correa Am, Gilcrease M, Isobe T, Massarelli E, Bucanna CD, O?Reilly MS, Hong WK, Fidler IJ, Putnam, JB Jr., Herbst RS. Synchronous overexpression of epidermal growth factor receptor and HER@-neu protein is a predictor of poor outcome in patients with state I non-small cell lung cancer. Clin Cancer Res, 10 (1 Pt 1)(Jan 1), 136-43, 2004

Swisher SG, Eramus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam, JB Jr., Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. . 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer, 101 (8)(Oct 15), 1776-85, 2004


Postdoctoral Position Available
N/A

Postdoctoral Position Details
N/A

Updated Date
09/23/2011